3D Signatures Inc’s Stock Is Sell After Today’s Huge Decline

 3D Signatures Inc's Stock Is Sell After Today's Huge Decline

The stock of 3D Signatures Inc (CVE:DXD) is a huge mover today! About 100,053 shares traded hands. 3D Signatures Inc (CVE:DXD) has risen 6.00% since October 16, 2016 and is uptrending. It has outperformed by 2.07% the S&P500.
The move comes after 5 months negative chart setup for the $44.53M company. It was reported on Nov, 15 by Barchart.com. We have $0.81 PT which if reached, will make CVE:DXD worth $5.34M less.

More notable recent 3D Signatures Inc (CVE:DXD) news were published by: Marketwired.com which released: “3D Signatures Inc. Introduces Internationally Recognized Clinical and …” on November 14, 2016, also Marketwired.com with their article: “3D Signatures Inc. Announces Closing of Qualifying Transaction” published on September 09, 2016, Finance.Yahoo.com published: “3D Signatures Inc. Appoints Jason Flowerday as New CEO” on September 27, 2016. More interesting news about 3D Signatures Inc (CVE:DXD) were released by: Marketwired.com and their article: “3D Signatures Inc. and Plicit Capital Corp. Increase Minimum Financing and …” published on May 26, 2016 as well as Marketwired.com‘s news article titled: “3D Signatures Inc. Commences Trading September 13th Under the Symbol (TSX …” with publication date: September 12, 2016.

3D Signatures Inc, formerly Plicit Capital Corp, is a Canada personalized medicine firm with a software platform based on the three-dimensional analysis of telomere organization. The company has a market cap of $44.53 million. The Company’s software technology and prognostic methodology targets various diseases that demonstrate genomic instability, including cancer and neurological disorders. It currently has negative earnings. It is engaged in developing over five diagnostic and prognostic products for cancers and neurological disorders, including 3D Telo-PC, 3D Telo-RS, 3D Telo-MM, 3D Telo-BC, 3D Telo-LC and 3D Telo-AD.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Related posts

Leave a Comment